| 2024 |
Neurocrine Biosciences, Inc.
|
Independent Director |
499.1 K |
0.4 % |
| 2024 |
Organon & Co.
|
Independent Director |
345 K |
0.0 % |
| 2024 |
BeiGene Ltd - ADR
|
Director |
303.1 K |
- |
| 2024 |
Septerna Inc.
|
Independent Director |
278.9 K |
- |
| 2024 |
BeiGene Ltd - ADR
|
Director |
- |
- |
| 2023 |
Neurocrine Biosciences, Inc.
|
Independent Director |
497.1 K |
0.0 % |
| 2023 |
Organon & Co.
|
Independent Director |
345 K |
0.0 % |
| 2023 |
Sutro Biopharma Inc
|
Independent Director |
16.6 K |
-85.8 % |
| 2022 |
Mirati Therapeutics Inc
|
Independent Director |
695.4 K |
- |
| 2022 |
Neurocrine Biosciences, Inc.
|
Independent Director |
497.0 K |
1.8 % |
| 2022 |
Organon & Co.
|
Independent Director |
345 K |
-17.5 % |
| 2022 |
Sutro Biopharma Inc
|
Independent Director |
116.9 K |
-59.8 % |
| 2022 |
Precision Biosciences Inc
|
Independent Director |
- |
- |
| 2021 |
Neurocrine Biosciences, Inc.
|
Independent Director |
488.5 K |
-43.7 % |
| 2021 |
Organon & Co.
|
Independent Director |
418.3 K |
- |
| 2021 |
Sutro Biopharma Inc
|
Independent Director |
290.6 K |
130.8 % |
| 2021 |
Precision Biosciences Inc
|
Independent Director |
234.3 K |
-2.7 % |
| 2020 |
Neurocrine Biosciences, Inc.
|
Independent Director |
868.0 K |
- |
| 2020 |
Precision Biosciences Inc
|
Independent Director |
240.8 K |
336.5 % |
| 2020 |
Sutro Biopharma Inc
|
Independent Director |
125.9 K |
-2.5 % |
| 2020 |
Organon & Co.
|
Independent Director |
- |
- |
| 2019 |
Sutro Biopharma Inc
|
Independent Director |
129.2 K |
-59.2 % |
| 2019 |
Precision Biosciences Inc
|
Independent Director |
55.2 K |
-95.5 % |
| 2019 |
Neurocrine Biosciences, Inc.
|
Independent Director |
- |
- |
| 2018 |
Precision Biosciences Inc
|
Independent Director |
1.2 M |
- |
| 2018 |
Sutro Biopharma Inc
|
Independent Director |
316.6 K |
- |
| 2018 |
Agenus Inc
|
Independent Director |
- |
- |
| 2017 |
Agenus Inc
|
Independent Director |
167.1 K |
-10.9 % |
| 2016 |
Agenus Inc
|
Independent Director |
187.5 K |
29.6 % |
| 2015 |
Agenus Inc
|
Independent Director |
144.6 K |
109.3 % |
| 2014 |
Agenus Inc
|
Director |
69.1 K |
-12.1 % |
| 2013 |
Agenus Inc
|
Director |
78.7 K |
44.7 % |
| 2012 |
Agenus Inc
|
Director |
54.4 K |
- |
| 2011 |
Agenus Inc
|
Director, Vice President and Chief Financial Officer |
- |
- |